FDA Panel: New MS Drug Helps Walking

Ampriva helps some multiple sclerosis patients walk better, an FDA advisory panel says. The finding makes it more likely that full FDA approval will come soon.

Related posts:

1. Ampyra receives FDA approval for improving walking in MS patients
2. FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
3. FDA’s Ampyra approval wonderful news for people with MS experiencing walking problems